Bicycle therapeutics strengthens board of directors with new appointments

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced the appointments of roger dansey, m.d., and hervÉ hoppenot to the company's board of directors. "we are thrilled to welcome roger and hervÉ to our board of directors as we make strong progress across our pipeline and anticipate numerous upcoming mi.
BCYC Ratings Summary
BCYC Quant Ranking